Knowledge

Ulthera DS 7-3.0 Transducer: Technology, Uses, and Clinical Benefits

Posted on by allwill-admin

The Ulthera DS 7-3.0 transducer is a 7 MHz micro‑focused ultrasound handpiece cartridge engineered to deliver energy precisely at a depth of 3.0 mm in the skin, targeting the deep dermis for lifting and tightening. It has become a cornerstone transducer in Ultherapy treatment protocols for mid‑face, jawline, neck, and décolletage rejuvenation because it balances lifting power, collagen stimulation, and patient comfort.

What Is the Ulthera DS 7-3.0 Transducer?

The Ulthera DS 7-3.0 transducer (often labeled DS 7–3.0 or DS 7–3.0N Green) is a replaceable ultrasound cartridge used with the Ulthera or Ultherapy system to deliver micro‑focused ultrasound energy at a fixed depth of 3.0 mm. Ulthera’s DeepSEE technology combines real‑time ultrasound imaging with therapeutic ultrasound, and the DS 7-3.0 transducer is calibrated to fire precise lines of energy in the deep dermis where structural collagen fibers reside.

This transducer operates at a treatment frequency of approximately 7 MHz and is classified as a medium‑depth cartridge, bridging the gap between superficial 1.5 mm rejuvenation and deeper 4.5 mm SMAS lifting. In practice, the DS 7-3.0 transducer is used in layered Ultherapy protocols, often following a 4.5 mm pass and sometimes combined with 1.5 mm passes for texture, to create a three‑level tightening effect.

Because it is specifically designed for non‑invasive facial lifting and tightening, the DS 7-3.0 transducer is widely used in medical aesthetic practices for patients with mild to moderate skin laxity who want visible tightening without surgery, incisions, or downtime.

Core Technology: 7 MHz Micro‑Focused Ultrasound at 3.0 mm

At the heart of the Ulthera DS 7-3.0 transducer is micro‑focused ultrasound energy delivered at a fixed focal depth of 3.0 mm beneath the skin surface. The cartridge emits ultrasound in discrete, precisely spaced thermal coagulation points along each treatment line, creating controlled zones of thermal injury in the deep dermis while sparing the epidermis.

The 7 MHz frequency allows the transducer to focus energy with high spatial precision, which is critical for targeting collagen‑rich structures without damaging intervening tissues. Real‑time DeepSEE imaging enables the practitioner to visualize tissue layers and align each shot exactly at 3.0 mm, optimizing safety and consistency from patient to patient.

This controlled thermal effect, usually at temperatures in the range used for collagen denaturation and neocollagenesis, stimulates immediate collagen contraction and triggers a months‑long remodeling response. As fibroblasts synthesize new collagen and reorganize existing fibers, the skin gradually becomes firmer, tighter, and more lifted, particularly in areas prone to sagging such as the lower face and neck.

Treatment Depth and Anatomical Targets of 3.0 mm

The 3.0 mm depth corresponds primarily to the deep dermis and upper subcutaneous fat layer in most facial regions. This is the zone where vertical collagen fibers and fibrous septae support superficial soft tissues and contribute significantly to visible skin firmness.

In areas with thicker skin or more subcutaneous fat, such as the cheeks or submental region, the 3.0 mm transducer can also influence fibroseptal networks and contribute to improved contour along the jawline. In regions with thinner skin, like parts of the jawline or periorbital region, 3.0 mm may lie closer to the superficial musculoaponeurotic system (SMAS), allowing some lifting effect without fully penetrating to SMAS depth.

Because the DS 7-3.0 transducer is calibrated for this specific anatomical zone, it plays a crucial role in bridging deep structural lifting with visible dermal tightening. When combined with 4.5 mm SMAS‑targeting cartridges, it enhances upper tissue support; when combined with 1.5 mm cartridges, it complements surface‑level texture improvements.

Key Clinical Benefits of the Ulthera DS 7-3.0 Transducer

The Ulthera DS 7-3.0 transducer offers multiple patient‑centered and practice‑centered benefits that explain its widespread adoption in modern Ultherapy protocols.

First, it provides non‑surgical lifting and tightening of the mid and lower face, jawline, and neck by stimulating collagen in the deep dermis without incisions or downtime. Many patients report gradual improvement in cheek sagging, jowl definition, and under‑chin laxity over three to six months as new collagen forms.

Second, the 3.0 mm depth is highly effective for collagen remodeling without the higher discomfort sometimes associated with deeper SMAS‑level treatment alone. This makes the DS 7-3.0 a favorable choice for patients with moderate pain sensitivity or for touch‑up sessions when full‑intensity deep passes are not required.

Third, clinical studies on micro‑focused ultrasound indicate that mid and lower face tightening using 3.0 mm probes can achieve measurable improvement in contour and skin firmness, supporting its role as a core transducer in evidence‑based Ultherapy treatment plans. Importantly, results typically last 12–18 months or longer, depending on patient age, skin quality, and lifestyle factors.

Fourth, the transducer’s imaging‑guided application improves safety, reducing the risk of energy delivery to inappropriate depths or sensitive structures. This is especially relevant in areas with variable anatomy, where precise 3.0 mm targeting minimizes unwanted fat atrophy or nerve irritation when used according to recommended protocols.

Typical Treatment Areas and Indications at 3.0 mm

The Ulthera DS 7-3.0 transducer is commonly indicated for patients presenting with mild to moderate skin laxity and early signs of aging who want a non‑invasive solution for lifting and tightening. It is frequently used on the following areas:

Cheeks: To improve mid‑face sagging, nasolabial fold prominence, and cheek heaviness by tightening the deep dermal support structures.
Jawline: To enhance mandibular contour, reduce early jowl formation, and create a more defined lower facial profile.
Submental region: To address under‑chin laxity and soft tissues contributing to the appearance of a double chin.
Neck: To tighten loose skin and horizontal neck lines by stimulating collagen in the deep dermis.
Lower face: To soften marionette lines and improve the transition between the jawline and neck.

Also check:  How Is a Medical Technology Solutions Provider Transforming Health Innovation and Efficiency?

In some protocols, the DS 7-3.0 transducer is also applied carefully around the perioral area and along the lateral brow to support lifting and wrinkle reduction, always guided by imaging and depth awareness.

How the DS 7-3.0 Transducer Fits in Multi‑Depth Ultherapy Protocols

Modern Ultherapy protocols rarely rely on a single transducer. Instead, practitioners develop layered protocols that use multiple depths to treat the complete soft‑tissue architecture. The Ulthera DS 7-3.0 transducer is a central part of this multi‑layer approach.

A typical protocol for mid and lower face lifting might begin with a 4.5 mm SMAS‑targeting pass to lift deeper support structures, followed by a 3.0 mm pass to tighten the deep dermis and improve skin firmness. A final 1.5 mm pass may be used in selected areas to refine superficial wrinkles and skin texture.

Within this schema, the 3.0 mm transducer provides the critical interface between deep foundational lift and visible surface improvement. It ensures that collagen remodeling occurs in the layer closest to what patients see in the mirror, translating energy delivery into perceivable tightening over time.

For maintenance treatments, practitioners may prioritize the DS 7-3.0 transducer because it can refresh collagen and maintain results without always needing full SMAS‑level retreatment, making it a flexible tool for long‑term Ultherapy programs.

Technical Specifications and Safety Features

From a technical standpoint, the Ulthera DS 7-3.0 transducer is designed to integrate seamlessly with Ulthera systems such as UT‑series platforms. It is identified by labeling that includes its name, frequency (7 MHz), and treatment depth (3.0 mm), ensuring the practitioner selects the correct cartridge for the intended anatomical layer.

Energy parameters can be adjusted according to treatment area, patient tolerance, and protocol guidelines, while internal sensors and system software manage calibration and temperature to maintain performance. Many units include overheat protection functionalities and automatic calibration routines that help preserve dosing accuracy and device longevity.

The cartridge itself is manufactured from medical‑grade, biocompatible materials designed for repeated contact with skin under ultrasound coupling gel. Proper maintenance and replacement at manufacturer‑recommended shot counts are essential for consistent line quality, accurate depth targeting, and predictable clinical outcomes.

Market Trends and Demand for 3.0 mm Ultherapy Transducers

Demand for the Ulthera DS 7-3.0 transducer is closely tied to the broader growth of non‑invasive skin tightening and energy‑based facial rejuvenation. As patients increasingly seek non‑surgical alternatives to facelifts with minimal downtime, micro‑focused ultrasound has secured a strong position alongside radiofrequency and laser devices in aesthetic clinics worldwide.

Reports from industry analysts have highlighted steady expansion in the global medical aesthetics market, with ultrasound‑based skin tightening singled out as a key growth category due to its combination of safety, efficacy, and natural‑looking outcomes. In this context, 3.0 mm cartridges occupy a particularly important niche because they serve the largest demographic segment: patients with early to moderate laxity who want lifting but are not yet candidates for surgery.

Clinics that incorporate the DS 7-3.0 transducer into standardized Ultherapy protocols often market its ability to address midface sagging, jowling, and neck laxity in a single session with progressive results. As consumer awareness increases, more patients explicitly ask for Ultherapy and, by extension, the targeted benefits of the 3.0 mm depth in their consultations.

At this point in the article, it is useful to recognize that solution‑focused partners are shaping how practitioners access and support devices. ALLWILL is redefining B2B medical aesthetics by aligning innovation, transparent vendor management, and comprehensive device lifecycle support so that clinics can confidently deploy technologies like Ulthera transducers while controlling cost of ownership and service risk.

Clinical Outcomes and Evidence for 3.0 mm Ultrasound

Clinical literature on micro‑focused ultrasound has demonstrated significant improvements in mid and lower face sagging when using 3.0 mm and 4.5 mm probes in combination. In studies of adult patients treated for midface and lower face laxity, 3.0 mm transducers targeting the deep dermis have produced measurable lifting and contour enhancement with high rates of patient satisfaction.

Patients typically experience a staged result profile. Immediately after treatment, a subset notice subtle tightening from collagen contraction and mild tissue edema. Over the following 8–12 weeks, neocollagenesis and collagen remodeling become more apparent, with improved jawline definition, reduced sagging around the mouth, and smoother transition between face and neck. Maximum visible improvement is often reported around the three‑ to six‑month mark.

Durability varies but commonly extends beyond one year, with some patients maintaining noticeable benefits for up to 18–24 months, especially if they adhere to healthy lifestyle practices and sun protection. For many, a maintenance session using DS 7-3.0 and companion cartridges every 12–18 months helps sustain lifting and delay the need for surgical intervention.

Practical Benefits for Practitioners Using DS 7-3.0

For practitioners, the Ulthera DS 7-3.0 transducer has several practical advantages. Because it targets a depth that is highly relevant to visible skin firmness, it often delivers improvements that patients can clearly appreciate in before‑and‑after photos, which supports patient satisfaction and practice growth.

Also check:  How Coolwaves® Technology Revolutionizes Non-Surgical Lipolysis: Deka Onda Pro Deep Dive

The 3.0 mm depth offers a favorable balance between efficacy and comfort. While numbing strategies and patient counseling are still important, many patients tolerate DS 7-3.0 passes relatively well compared with deeper SMAS‑focused passes, which can be more intense. This can shorten chair time, reduce anxiety, and encourage repeat treatments.

In addition, the standardized shot mapping and imaging‑guided delivery associated with Ultherapy and DS 7-3.0 enable consistent outcomes across different operators, provided adequate training and adherence to manufacturer guidelines. This reproducibility is vital for multi‑provider clinics and large networks aiming for uniform quality standards.

Patient Experience: What to Expect with a 3.0 mm Ultherapy Session

From a patient’s perspective, treatment with the Ulthera DS 7-3.0 transducer typically begins with photographic documentation and mapping of treatment zones along the cheeks, jawline, submental region, and neck. After a cleansing and marking process, ultrasound gel is applied, and the transducer is placed on the skin while the practitioner uses imaging to confirm the correct depth.

When shots are fired, patients often describe sensations of heat, tingling, or mild to moderate discomfort along each line, reflecting the focused thermal effect in the deep dermis. Comfort measures may include topical anesthetic, oral analgesics, or cooling strategies, depending on clinic protocols and individual sensitivity.

Post‑treatment, patients can usually return to normal activities immediately. Temporary side effects may include mild redness, tenderness, swelling, or transient tingling, which typically resolve over hours to days. Bruising is uncommon but can occur, particularly in areas with more superficial vessels. Serious adverse events are rare when appropriate energy settings, imaging, and anatomical awareness are applied.

Real‑World Case Examples and ROI for Clinics

Consider a clinic that introduces Ultherapy with a focus on midface and lower face lifting using DS 7-3.0 combined with 4.5 mm cartridges. Over the first year, they treat a series of patients aged 35–60 with mild to moderate laxity who are not ready for facelift surgery. A large proportion of these patients demonstrate visible improvement in jowl contour, cheek sagging, and neck tightness on standardized photography at three and six months.

Some patients who initially booked treatment for the lower face return to expand coverage to the brow or décolletage once they see progressive tightening from their 3.0 mm sessions. Others schedule maintenance sessions at 12–18 months, building a recurring revenue base for the practice. Patient word‑of‑mouth and online reviews referencing the natural, gradual results achieved with Ultherapy help attract new inquiries.

From an ROI standpoint, the DS 7-3.0 transducer contributes by enabling high‑value treatments with relatively low consumable cost per session compared with many disposable‑heavy technologies. When combined with efficient scheduling, clear pre‑consultation education, and photography documentation, clinics can position Ultherapy as a premium yet cost‑effective alternative to early surgical intervention.

Comparing Ulthera DS 7-3.0 with Other Ultherapy Transducers

To understand the role of the DS 7-3.0 transducer, it is useful to compare it side by side with other common Ultherapy cartridges.

Transducer Name Frequency / Depth Primary Tissue Target Key Use Cases Relative Sensation
DS 4-4.5 ~4 MHz / 4.5 mm SMAS / deep fascia Deep lifting of midface, jawline, neck Often most intense
DS 7-3.0 ~7 MHz / 3.0 mm Deep dermis / upper subcutis Midface and lower face tightening, jowls, neck Moderate
DS 10-1.5 ~10 MHz / 1.5 mm Superficial dermis Fine lines, texture, periorbital and perioral refinement Mild to moderate

While the 4.5 mm cartridge is crucial for foundational lifting, the DS 7-3.0 transducer is the workhorse for visible tightening and contouring in the deep dermis. The 1.5 mm cartridge completes the trio by enhancing surface texture and fine wrinkles. Together, they enable comprehensive multi‑layer Ultherapy.

Competitive Landscape and Device Alternatives

In the broader non‑invasive tightening landscape, the Ulthera DS 7-3.0 transducer competes indirectly with monopolar radiofrequency systems, multipolar RF devices, high‑intensity focused ultrasound variants from other manufacturers, and fractional lasers aimed at tightening the dermis. Each modality offers a different energy type, depth profile, and patient experience.

Compared to many radiofrequency devices that rely on bulk heating and less precise depth control, micro‑focused ultrasound at 3.0 mm offers sharply defined focal zones and real‑time imaging. This can translate into more targeted collagen stimulation with reduced risk of unnecessary surface heating or inconsistent depth. On the other hand, radiofrequency may provide more diffuse heating and can be advantageous for certain indications like crepey surface texture.

High‑intensity focused ultrasound platforms that lack imaging capabilities may approximate the depth of 3.0 mm but cannot verify tissue layer placement in real time. The integration of imaging in Ulthera systems, combined with calibrated transducers like DS 7-3.0, remains a key differentiator in terms of precision and safety profile.

Maintenance, Calibration, and Best Practices

To maintain consistent performance of the Ulthera DS 7-3.0 transducer, clinics must follow best practices for shot counting, calibration, and storage. Each cartridge is rated for a finite number of lines, and exceeding this limit can compromise energy delivery, depth accuracy, and clinical results. Practices should track usage closely within the system interface and replace cartridges when indicated.

Also check:  Are Membrane Oxygenator Disposable Units Safe?

Routine system checks, including verification of imaging clarity and energy output, help ensure that each 3.0 mm shot reaches the intended tissue layer. Proper cleaning and handling between patients, adhering to manufacturer guidelines, preserve the integrity of the coupling surface and prevent artifacts that might affect shot placement.

Training is critical. Providers should understand the anatomy of each treatment area at the 3.0 mm depth, including nerves, vessels, and fat compartments, and use ultrasound imaging to avoid sensitive structures. Adhering to recommended line patterns, spacing, and energy levels for specific indications supports reproducible outcomes and minimizes complications.

Future Trends: Evolving Use of 3.0 mm Micro‑Focused Ultrasound

Looking ahead, the role of the Ulthera DS 7-3.0 transducer is likely to expand as protocols become more personalized and as combination treatments gain traction. Personalized protocols may adjust shot density, line patterns, and combinations of depths based on individual skin thickness, laxity patterns, and facial fat distribution.

Combination therapies pairing 3.0 mm Ultherapy with injectable fillers, biostimulatory injectables, neuromodulators, and regenerative approaches like platelet‑rich plasma or exosomes are already being explored in clinical practice. In such combinations, DS 7-3.0 provides structural tightening and collagen support, while other modalities address volume, dynamic lines, or skin quality.

Future device iterations may offer even more refined imaging, AI‑assisted mapping, or transducers with variable focal depths around the 3.0 mm range to better match diverse anatomy. However, the core principle will remain the same: precisely delivered micro‑focused ultrasound at the deep dermis remains a powerful tool for non‑invasive lifting and tightening.

Frequently Asked Questions About the Ulthera DS 7-3.0 Transducer

What Are the Specifications of the Ulthera DS 7-3.0 Transducer
The Ulthera DS 7-3.0 transducer delivers precise high-frequency ultrasound at 7 MHz with a 3.0 mm depth. It’s engineered for targeted skin lifting and tightening, offering consistent energy delivery for safe, predictable outcomes. ALLWILL ensures all devices meet rigorous inspection standards, maximizing clinical reliability.

How Do Ulthera DS 7-3.0 Frequency Settings Affect Treatments
Adjusting the frequency settings on the Ulthera DS 7-3.0 alters penetration depth and treatment precision. Higher frequencies target superficial layers, while lower frequencies reach deeper tissue for lifting. Understanding these settings optimizes patient results and safety. ALLWILL provides guidance on proper calibration and usage.

How Deep Does the Ulthera DS 7-3.0 Transducer Penetrate Skin
The Ulthera DS 7-3.0 transducer penetrates approximately 3.0 mm into the dermis, ideal for non-invasive lifting and tightening of mid-to-deep skin layers. This depth ensures effective collagen stimulation while minimizing downtime and discomfort. Proper technique ensures consistent, visible results.

What Are the Key Features of the Ulthera DS 7-3.0 Transducer
Key features include high-frequency ultrasound, precise energy delivery, and ergonomic design for targeted facial and neck treatments. It enables controlled tissue heating and lifting, improving patient outcomes. These attributes make it a preferred choice for practitioners seeking efficient, reliable non-invasive procedures.

How to Use Ulthera DS 7-3.0 for Effective Skin Tightening
For skin tightening, apply the Ulthera DS 7-3.0 transducer in slow, overlapping passes at proper depth and energy levels. Focus on sagging areas while maintaining patient comfort. Adequate training ensures predictable collagen remodeling and visible lifting results. ALLWILL’s training resources help optimize technique.

How Does Ulthera DS 7-3.0 Improve Patient Outcomes
The Ulthera DS 7-3.0 enhances patient outcomes by delivering precise ultrasound energy to targeted tissue, stimulating collagen production and promoting natural skin tightening. Results are consistent, non-invasive, and long-lasting when protocols are followed. This improves satisfaction and reduces retreatment needs.

What Is the Safety Profile of the Ulthera DS 7-3.0 Transducer
The device has a strong safety profile with minimal adverse effects when used correctly. Controlled energy delivery, proper depth selection, and patient assessment prevent complications. Post-treatment recovery is quick, making it suitable for sensitive areas like the neck and under-eye region.

Where Can You Purchase the Ulthera DS 7-3.0 Transducer
Ulthera DS 7-3.0 transducers are available from authorized vendors or trusted B2B platforms. ALLWILL offers brand-agnostic sourcing, refurbished units, and trade-up programs, ensuring verified, fully functional devices without service or recertification headaches. Consult with experts for optimal selection and delivery.

Natural Conversion Path: From Interest to Long‑Term Ultherapy Planning

Patients typically begin their journey with online research about non‑surgical facial tightening and Ultherapy, then progress to in‑clinic consultations where clinicians explain how the Ulthera DS 7-3.0 transducer targets the deep dermis to improve midface, jawline, and neck firmness. Clear education, realistic expectations, and visual examples of typical three‑ to six‑month outcomes help move patients from curiosity to commitment.

After an initial Ultherapy session using DS 7-3.0 in combination with other depths, follow‑up visits at eight to twelve weeks can reinforce patient satisfaction by documenting progressive changes and discussing next steps. At this stage, clinics can introduce options for adjunctive treatments or long‑term maintenance plans that maintain the benefits of collagen stimulation at 3.0 mm and beyond.

For practices that structure their offerings thoughtfully, the Ulthera DS 7-3.0 transducer becomes more than just a cartridge: it becomes a central component in a comprehensive, layered strategy for non‑invasive lifting, anchoring both clinical outcomes and sustainable business growth in the rapidly expanding field of energy‑based medical aesthetics.

allwill-admin

联系我们|Contact Form

TERMS AND CONDITIONS 

These Terms and Conditions (these “Terms”), together with the attached or accompanying quote page (the “Quote,” collectively, this “Agreement”), exclusively govern the sale by Healthcare Markets, Inc., a Delaware corporation doing business as “Powered by MRP” (“MRP”), and the purchase and use by the buyer set forth on the Quote (“Buyer”), of the equipment (the“Equipment”) and/or services (the “Services”).

        1.  EQUIPMENT AVAILABILITY. Equipment offered for sale by MRP is subject to availability. MRP shall not be liable to Buyer in case of stock outage or unavailability of the Equipment. MRP reserves the right to change the equipment offered for sale at any time and without notice to Buyer. Availability of equipment may be determined when an order is placed, and, if unavailable, MRP will inform Buyer of such unavailability, offer other available equipment as substitution or cancel the order. Such cancelled order will be refunded by MRP to Buyer, except for an order for a Special Order Product, which cannot be cancelled once the order is placed.

        2.  PRICES. Written price quotations on the Quote shall last for ten (10) days from the date issued and then automatically expire, and quoted prices do not include taxes, freight, handling, duty, insurance or other similar charges, which Buyer must pay unless waived in writing by MRP or a valid tax exemption certificate is provided to MRP. Notwithstanding the foregoing, all published prices may be changed by MRP at any time without notice to Buyer.

        3.  TERMS OF PAYMENT. Unless otherwise agreed to on the Quote or in writing by MRP, prepayment in full is required, by bank transfer, cash, credit card or certified check, and where partial pre-payment is permitted, such payment shall be nonrefundable with the balance due net thirty (30) days from the date of invoice. MRP reserves the right to modify or revoke any credit previously extended. Past due balances shall be subject to a service charge of one and one-half percent (1.5%) per month, not to exceed the maximum amount permitted by applicable law. Buyer agrees to pay all fees, charges or other sums payable hereunder, including collection fees incurred, with no right of set-off or reduction of any nature unless approved in writing by an MRP corporate officer (an “MRP Officer”). Buyer hereby grants, and MRP reserves, a purchase money security interest in the Equipment purchased, and in any proceeds thereof, to secure Buyer’s payment obligations hereunder. Buyer shall cooperate fully with MRP to execute such documents and accomplish such filings and/or recordings as MRP may deem necessary for the protection of its interests in the Equipment furnished to Buyer, and in the event Buyer does not aid within a reasonable time after MRP asks Buyer to do so, Buyer hereby authorizes and appoints MRP as Buyer’s attorney-in-fact to execute, deliver and file at any time, any financing statement and/or take any other action permitted by applicable law to perfect, enforce, continue and amend MRP’s security interest in any jurisdiction deemed appropriate by MRP. Buyer agrees that upon nonpayment of any charges due to MRP, MRP may cancel or delay delivery of the Equipment and/or suspend any applicable service coverage, which may resume only when MRP receives payment in full, and the warranty period will continue to run during such time of nonpayment although warranty service will not be available.

        4.  SHIPMENT AND DELIVERY. Delivery dates are estimated, and partial deliveries are allowed. MRP shall not be liable for or in respect of any loss or damage arising from any delay in filling any order, failure to deliver or delay in delivery. No delay in the shipment or delivery of any Equipment relieves Buyer of its obligations under this Agreement, including, without limitation, accepting delivery of any remaining installment(s) of the Equipment, if applicable. Buyer must pay for, and hold MRP harmless from, all shipping, delivery, and insurance expenses unless otherwise agreed in writing by an MRP Officer or otherwise indicated on the Quote. MRP will not assume any liability if MRP selects the shipping methods nor will any carrier be deemed to be MRP’s agent. “Time is of the essence” terms will not apply to orders accepted by MRP. Title and risk of loss of the Equipment shall pass to Buyer, and delivery shall be deemed completed, when the Equipment is delivered to Buyer’s address. Should loss or damage in transit occur, Buyer’s payment obligations will not be affected. Buyer is liable for all costs for MRP’s holding or storing of the Equipment if delivery is delayed by Buyer or at Buyer’s request. If delivery is delayed over thirty (30) days, MRP may, at its option and upon notice to Buyer, cancel that and all future deliveries without further liability or obligation of any kind.

        5.  FORCE MAJEURE. MRP shall not be responsible for delays or failure to render or service any Equipment and/or perform any Service due to any cause beyond MRP’s control, including, but not limited to: (a) acts of God; (b) flood, fire, earthquake, epidemic, pandemic or explosion; (c) war, invasion, hostilities (whether war is declared or not), terrorist threats or act, riot or other civil unrest; (d) government order, law or actions; (e) embargoes or blockades in effect on or after the date of this Agreement; (f) national or regional emergency; (g) strikes, labor stoppages or slowdowns or other industrial disturbances; and (h) telecommunication breakdowns, power outages or shortages, lack of warehouse or storage space, inadequate transportation services or inability or delay in obtaining supplies of adequate or suitable material (each, a “Force Majeure Event”). Any delivery date may be extended, at MRP’s sole discretion, to the extent of any delay resulting from any Force Majeure Event.

        6.  ACCEPTANCE; INSPECTION. Except for Special Order Products, Buyer shall inspect all Equipment upon delivery and within forty-eight (48) hours of delivery to Buyer shall give written notice to MRP of any error or claim that any Equipment does not conform to the terms of this Agreement; any claims not made within such period shall be deemed waived and released, with the Equipment being accepted by Buyer. Except as provided under this Section 6 and Section 7 hereof, all sales of Equipment to Buyer are made on a one-way basis, and Buyer has no right to return Equipment purchased under this Agreement to MRP. Subject to the warranty set forth in Section 8(c)(iv), Services are deemed to be accepted by Buyer upon completion of their performance by MRP.

        7.  CANCELLATION CHARGES AND RETURNED EQUIPMENT POLICY. Returns and cancellations are not permitted without written approval by an MRP Officer, which shall be made in such MRP Officer’s sole discretion. If approved, MRP will issue a return merchandise authorization number, which Buyer must include in the returned packaging, and Buyer must pay MRP either a (a) twenty percent (20%) restocking charge on the purchase price of the item if Buyer’s written request for return or cancellation is received by MRP’s headquarters after MRP’s original shipment of the Equipment or (b) a ten percent (10%) cancellation damages charge if Buyer’s request was received before said shipment. The foregoing charges are agreed upon, not as a penalty, but because of the difficulty of computing actual damages, and until the applicable charge is paid and the Equipment has been received back by MRP in new condition, no refund will be given. This document or copies hereof may be filed with the appropriate authorities as a financing statement to pursue such charges. In no case will shipping and freight costs be refunded. Removed, replaced or substituted equipment and parts (collectively, “Returned Equipment”) shall become MRP’s property, with title and ownership transferring to MRP upon the earlier of its return or replacement, with MRP owing no other obligations on the Returned Equipment. Buyer hereby agrees to indemnify, defend and hold harmless MRP Indemnitees from any claims, costs, losses, attorneys’ fees and expenses related to any third-party attempts to claim ownership of the Returned Equipment or dispute any trade-in, removal, substitution or replacement, and the remaining provisions shall continue in full force and effect.

        8.  MRP’S WARRANTIES, IF ANY.

(a) Equipment Sold “As Is.” UNLESS OTHERWISE STATED ON THE QUOTE OR IN A WRITING SIGNED BY AN MRP OFFICER, BUYER AGREES THAT THE EQUIPMENT SOLD IN THIS AGREEMENT IS BEING SOLD ON AN “AS IS,” “AS AVAILABLE” BASIS, SUBJECT TO SECTIONS 8(c) AND 9, AND HAVE NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, WHETHER IMPLIED OR ARISING BY LAW, STATUTE OR OTHERWISE, INCLUDING, WITHOUT LIMITATION, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, NON-INFRINGEMENT, WORKMANLIKE MANNER, QUALITY, ACCURACY, TITLE, AND/OR IMPLIED FROM A COURSE OF DEALING OR PERFORMANCE USAGE IN TRADE.

(b) Special Order Product. If this Agreement includes the sale of a product that MRP does not currently have or typically keep in stock, in MRP’s sole determination, but is acquired from a third party specifically for Buyer (a “Special Order Product”), then Buyer agrees that (i) Buyer, at its sole discretion, has made the selection of such Special Order Product, (ii) such Special Order Product is being acquired by MRP solely at the request of Buyer, (iii) no representation, warranty or guarantee has been made by MRP with respect to such Special Order Product, (iv) the obligation of Buyer to pay MRP for the Special Order Product is absolute and unconditional, and (v) Buyer waives and releases MRP from all claims, damages and losses arising out of such Special Order Product. Special Order Products carry no right to inspection before or after delivery, and MRP is not responsible for examining or evaluating such Special Order Products. MRP makes no warranty about Special Order Products and offerings of the third party (including description of the Special Order Product). MRP does not assume any responsibility or liability for the actions, product and content of all these and any other third parties. If there are any problems with any Special Order Product, Buyer must contact the manufacturer of such Special Order Product for assistance.

(c) Limited Warranties, If Any.

(i) If the Quote expressly states that the Equipment has a warranty for a certain time (a “Warranty Period”), then MRP warrants that the Equipment shall be in good working order under normal use for the Warranty Period, which Warranty Period shall commence from the date of delivery to Buyer (the “Delivery Date”), unless otherwise approved by an MRP Officer in writing, except for the following: (A) New (not used or pre-owned) Equipment that is to be serviced by MRP: if the Quote is silent, warranted to be in good working order under normal use for one hundred eighty (180) days from the Delivery Date; (B) Used Equipment sold refurbished by MRP: if the Quote is silent, warranted to be in good working order under normal use for thirty (30) days from the Delivery Date; (C) Consumable/disposable Equipment: if the Quote is silent, warranted to have been shipped from MRP in functional condition, and no additional warranty shall apply; no service shall be provided either. These items should be inspected for obvious damage, subject to Section 6 and 8(e), and MRP’s obligation under this warranty and this Section 8(c)(i)(C) is limited to replacement of the Equipment; and (D) New (not used or pre-owned) Equipment that is to be serviced by the manufacturer: if the Quote is silent, MRP makes no warranty for any such Equipment. Buyer’s sole warranty for any such Equipment, if any, shall be the original manufacturer’s warranty, which MRP agrees to pass on to Buyer, as applicable. (ii) For the limited warranties of Section 8(c)(i), including exceptions (A) and (B), but not (C) or this (D), Buyer is entitled to telephone, e-mail and video technical assistance and, subject to Sections 8(d) and 8(e), repair or replacement of such Equipment, in MRP’s sole discretion, should the Equipment become inoperative through normal use during the Warranty Period. Loaner equipment is not provided, but if so arranged by MRP, Buyer shall pay MRP the cash list price of any unreturned loaner equipment provided by MRP within seven (7) days of a written demand from MRP. (iii) Repair or replacement under any limited warranty of Equipment may be with parts or products that are new, used or refurbished, carrying the same limited warranty for the remaining term of the original item. Repairs or replacements shall not interrupt, extend or prolong the term of the warranty. (iv) For Services purchased under this Agreement, MRP warrants that the Services shall be performed using competent personnel in a professional manner in accordance with generally recognized industry standards for similar services. Subject to Sections 6 and 8(e) herein, if any Service was not performed in accordance with the aforementioned warranty, then MRP shall, in its sole discretion, either (A) repair or re-perform the applicable Service, or (B) credit or refund the price of such Service at the pro rata contract rate.

(d) Exclusions. MRP reserves the right, without liability, to void all warranties and remedies, including any obligation to service, repair, replace or otherwise remedy defects, errors or failures of the Equipment due to the occurrence of any of these events, and MRP shall be in no way responsible for: (i) handling, maintenance or use in a manner that is inconsistent with and/or contrary to the original manufacturer’s or MRP’s recommended procedures and/or instructions, including, without limitation, use of or with an unauthorized third-party good or part; (ii) any failure or damage resulting from negligence, alteration, modification or relocation of the Equipment by Buyer, its employees, agents or representatives; (iii) attempted or actual unauthorized dismantling, disassembling, service, repair, addition or change of the Equipment, including, without limitation, changing the serial number or shot count; (iv) abnormal wear and tear, including, without limitation, use under abnormal conditions (e.g., unclean, dusty, or exposure to extreme electromagnetic radiation, temperature or humidity); or (v) damage or failure of the Equipment due to a Force Majeure Event or a problem in the premises of the Equipment. In any of the above situations, or for any Equipment that has no warranty, MRP has sole discretion to service the Equipment, at Buyer’s expense, at MRP’s then-in-effect rates for service, labor, travel, shipping and materials.

(e) Notice and Inspection. The limited warranties contained in this Section 8 are made on condition that immediate written notice of any noncompliance with the Equipment’s and/or the Service’s warranty be given to MRP, and provided that MRP’s inspection reveals that Buyer’s claim is valid under the terms of such warranty.

        9.  DISCLAIMERS; NO OTHER WARRANTY. EXCEPT TO THE EXTENT AS PROVIDED IN SECTION 8(c)(i)(D), BUYER ACKNOWLEDGES THAT MRP IS NOT BOUND BY ANY WARRANTY THAT MAY BE SET FORTH IN A MANUFACTURER’S WRITTEN MATERIALS THAT WOULD HAVE APPLIED HAD BUYER PURCHASED THE EQUIPMENT DIRECTLY FROM THE MANUFACTURER IN ITS UNUSED STATE. BUYER ACKNOWLEDGES THAT BUYER HAS NOT RELIED UPON ANY WARRANTY OTHER THAN AS SET FORTH IN THIS AGREEMENT. IN ADDITION, BUYER ALSO HEREBY ACKNOWLEDGES AND AGREES THAT ANY ORAL OR WRITTEN STATEMENTS CONCERNING USE AND REGULATION OF MEDICAL DEVICES SOLD BY MRP ARE AND SHALL BE CONSTRUED AS FOR INFORMATIONAL PURPOSES ONLY AND WITHOUT WARRANTY OR ASSURANCE BY MRP AS TO THEIR ACCURACY OR VALIDITY. MRP ALSO HEREBY DISCLAIMS ANY AND ALL WARRANTIES REGARDING OTHER MEDICAL CARE OR HELP, INCLUDING THE SELECTION OF AESTHETIC AND MEDICAL PROCEDURES AND PRODUCTS FOR, OR CARE OF, PATIENTS. THE LIMITED WARRANTIES OF THIS AGREEMENT, IF APPLICABLE TO ANY EQUIPMENT OR SERVICE FURNISHED UNDER THIS AGREEMENT, CONSTITUTE THE ONLY WARRANTIES MADE WITH RESPECT TO THE EQUIPMENT AND/OR SERVICE AND ANY DEFECT, DEFICIENCY OR NONCONFORMITY. TO THE EXTENT PERMITTED BY LAW, SUCH WARRANTY IS IN LIEU OF ALL OTHER WARRANTIES, EXPRESS OR IMPLIED BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE, INCLUDING, BUT NOT LIMITED TO, ANY EXPRESS OR IMPLIED WARRANTY OF MERCHANTABILITY, TITLE, NONINFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE.

        10.  LIMITATION OF LIABILITY. NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS AGREEMENT, UNDER NO CIRCUMSTANCES SHALL MRP BE LIABLE FOR ANY INDIRECT, PUNITIVE, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY OR SPECIAL DAMAGES, ARISING FROM, RELATED TO OR CAUSED, DIRECTLY OR INDIRECTLY, WHETHER FORESEEABLE OR NOT, BY THE EQUIPMENT AND/OR THE SERVICES, THE USE OR INABILITY TO USE THE EQUIPMENT, THE RESULTS GENERATED FROM THE EQUIPMENT AND/OR THE SERVICES, THIS AGREEMENT, ANY OTHER ACT OR OMISSION OF MRP, OR BASED UPON ANY OTHER LEGAL THEORY. IN NO EVENT SHALL MRP BE LIABLE FOR ANY LOSSES OF REVENUE, USE, BUSINESS OPPORTUNITY, PROFIT, SAVINGS OR ANY OTHER DAMAGES DUE TO ANY CAUSE WHATSOEVER, EVEN IF MRP OR ITS AGENTS HAS BEEN ADVISED OF THE POSSIBILITY THEREOF. THE FOREGOING IS A SEPARATE, ESSENTIAL TERM OF THIS AGREEMENT, AND SHALL BE EFFECTIVE UPON THE FAILURE OF ANY REMEDY, EXCLUSIVE OR NOT. IN NO EVENT WILL MRP’S TOTAL LIABILITY UNDER THIS AGREEMENT EXCEED THE PURCHASE PRICE ACTUALLY PAID TO MRP BY BUYER FOR THE EQUIPMENT AND/OR THE SERVICES GIVING RISE TO THE CLAIM FOR WHICH DAMAGES ARE BEING SOUGHT. NO SUIT OR ACTION MAY BE BROUGHT BY BUYER, ITS SHAREHOLDERS, DIRECTORS, MANAGERS, EMPLOYEES OR AGENTS FOR ANY BREACH OF THIS AGREEMENT MORE THAN ONE (1) YEAR AFTER THE ACCRUAL OF SUCH CAUSE OF ACTION. IT IS AGREED THAT MRP’S LIABILITY IS SO LIMITED. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, BUYER ASSUMES ALL RISK AND LIABILITY FOR THE RESULTS OBTAINED BY THE USE OF ANY EQUIPMENT IN THE PRACTICE OF ANY PROCESS, WHETHER IN TERMS OF OPERATING COSTS, GENERAL EFFECTIVENESS, SUCCESS OR FAILURE, AND REGARDLESS OF ANY ORAL OR WRITTEN STATEMENTS MADE BY MRP, BY WAY OF TECHNICAL ADVICE OR OTHERWISE, RELATED TO THE USE OF THE EQUIPMENT.

        11.  BUYER’S REPRESENTATIONS AND WARRANTIES. Buyer represents and warrants to MRP that: (a) Buyer is duly organized, validly existing, and in good standing in the jurisdiction of Buyer’s formation; (b) Buyer is duly qualified to do business and is in good standing in every jurisdiction in which such qualification is required; (c) Buyer has the full right, power, and authority to enter into this Agreement and to perform Buyer’s obligations under this Agreement; (d) the execution of this Agreement by the person whose signature is set forth at the end hereof has been duly authorized by all necessary corporate action of Buyer; (e) when executed and delivered by each of MRP and Buyer, this Agreement will constitute the legal, valid and binding obligation of Buyer, enforceable against Buyer in accordance with its terms; (f) Buyer is in compliance with all applicable laws relating to this Agreement, the Equipment and the operation of Buyer’s business; (g) Buyer is not insolvent and is paying all of its debts as they become due; and (h) all financial information that Buyer has provided to MRP is true and accurate and fairly represents Buyer’s financial condition.

        12. PROPRIETARY RIGHTS.

(a) Ownership. No sale shall be construed as granting to Buyer any license or other right in, or to, any of MRP’s (i) patents; (ii) trademarks; (iii) internet domain names, whether or not trademarks, registered by any authorized private registrar or governmental authority, web addresses, web pages, websites and URLs; (iv) works of authorship, expressions, designs and design registrations, whether or not copyrightable, including copyrights and copyrightable works, software and firmware, technical data, data files, and databases and other specifications and documentation; (v) trade secrets; (vi) environmental or other testing applicable to the Equipment and/or the Services; and (vii) industrial and other intellectual property rights, and all rights, interests, and protections that are associated with, equivalent or similar to, or required for the exercise of, any of the foregoing, however arising, in each case whether registered or unregistered and including all registrations and applications for, and renewals or extensions of, such rights or forms of protection pursuant to the laws of any jurisdiction throughout in any part of the world (collectively, the “Intellectual Property Rights”).

(b) Prohibited Acts. Buyer shall not (i) take any action that might interfere with any of MRP’s rights in or to Intellectual Property Rights, including MRP’s ownership or exercise thereof; (ii) challenge any right, title, or interest of MRP in or to the Intellectual Property Rights; (iii) make any claim or take any action adverse to MRP’s ownership of the Intellectual Property Rights; (iv) register or apply for registrations, anywhere in the world, for MRP’s trademarks or any other trademark that is similar to MRP’s trademarks or that incorporates MRP’s trademarks in whole or in confusingly similar part; (v) use any mark, anywhere that is confusingly

similar to MRP’s trademarks in whole or in confusingly similar part; (vi) engage in any action that tends to disparage, dilute the value of or reflect negatively on the Equipment and/or the Services or any of MRP’s trademarks; (vii) misappropriate any of MRP’s trademarks for use as a domain name without prior written consent from MRP; or (viii) alter, obscure or remove any of MRP’s trademarks, or trademark or copyright notices or any other proprietary rights notices placed on the

Equipment, marketing materials or other materials that MRP may provide.

        13.  CONFIDENTIAL INFORMATION. Without the prior written consent of MRP,Buyer, directly or indirectly, shall not disclose (and will direct its directors, shareholders, employees and agents not to disclose) any Confidential Information. The term “Confidential Information” means any information of or relating to MRP or the Equipment and/or the Services not generally known to the public (other than as a result of disclosure in violation of this Agreement) in spoken, printed, electronic or any other form or medium, including, but not limited to, business processes, practices, methods, policies, plans, publications, documents, research, operations, services, strategies, techniques, agreements, contracts, transactions, potential transactions, know-how, trade secrets, databases, manuals, records, supplier information, financial information, accounting information, legal information, marketing information, pricing information, payroll information, personnel information, and supplier lists.

        14.  NON-SOLICITATION. Buyer agrees not to solicit or hire any personnel of MRP involved with the delivery of the Services during the provision of such Services and for twelve (12) months after the completion of such Services; provided, however, that Buyer may hire individuals employed by MRP who, without other solicitation, respond to advertisements or solicitations aimed at the general public.

        15.  EQUITABLE REMEDIES. Buyer acknowledges and agrees that (a) a breach or threatened breach by Buyer of any of its obligations under Sections 13 or 14 would give rise to irreparable harm to MRP for which monetary damages would not be an adequate remedy and (b) in the event of a breach or a threatened breach by Buyer of any such obligations, MRP shall, in addition to any and all other rights and remedies that may be available to MRP at law, at equity, or otherwise in respect of such breach, be entitled to equitable relief, including a temporary restraining order, an injunction, specific performance, and any other relief that may be available from a court of competent jurisdiction, without any requirement to post a bond or other security, and without any requirement to prove actual damages or that monetary damages will not afford an adequate remedy. Buyer agrees that Buyer will not oppose or otherwise challenge the appropriateness of equitable relief or the entry by a court of competent jurisdiction of an order granting equitable relief, in either case, consistent with the terms of this Section 15.

        16.  INDEMNIFICATION. Buyer agrees to indemnify, defend and hold harmless MRP and its directors, shareholders, employees and agents (collectively, “MRP Indemnitees”) against any liability, damage, loss or expense incurred by or imposed in connection with any claims, suits, actions, demands or judgments arising out of (a) any breach or non-fulfillment of any representation, warranty or covenant set forth in this Agreement by Buyer or its directors, managers, employees or agents (collectively, “Buyer’s Agents”); (b) any negligent act or omission or willful misconduct of Buyer or Buyer’s Agents in connection with this Agreement; (c) any bodily injury, death of any person or damage to real or tangible personal property caused by Buyer or Buyer’s Agents, including the use of unauthorized parts in or service of the Equipment; (d) any failure by Buyer or Buyer’s Agents to comply with any applicable laws; (e) any fraud or other intentional acts by Buyer or Buyer’s Agents; and (f) the use or operation of the Equipment, including, without limitation, any medical and/or surgical procedures performed by Buyer, and any of Buyer’s Agents, using the Equipment unless said damages are determined by a court of competence jurisdiction to be solely by the gross negligence of MRP or solely as result of a breach by MRP of the limited warranties contained herein.

        17.  DEFAULTS; REMEDIES. Notwithstanding anything herein to the contrary, should Buyer fail to pay for the order or any other amount, in whole or in part, when due or perform its other obligations under this Agreement or as otherwise mutually agreed in writing between Buyer and MRP (each, a “Default”), then MRP may take any and all actions available under law or equity to collect said amounts with a ten (10) day prior written notice, including, but not limited to, enforcing its security interest, accelerating the payment of and declaring immediately due and payable any unpaid balance of the order, referral to outside collection agencies and/or commencement of legal action. MRP’s rights shall be cumulative, and it shall not be required to have attempted to realize upon to the Equipment before taking any other collection actions. MRP may require that Buyer assemble and return any or all of the Equipment to MRP and, in the event Buyer fails to return such Equipment peaceably, enter upon the premises where such Equipment is located, with or without legal process, and repossess such Equipment. Upon a Default, Buyer agrees to pay upon MRP’s demand: (i) all costs and expenses incurred by MRP or its assignee in connection with the enforcement of any remedies, including all expenses incurred in connection with the return, sale, release or other disposition of the Equipment, including attorneys’ fees and other costs incurred by MRP or its assignee in enforcing or defending its rights and remedies under this Agreement and any other written agreement between Buyer and MRP.

        18.  COMPLIANCE WITH LAWS. Buyer shall (a) carry out the transactions contemplated by this sale and deal with the Equipment in conformity with all applicable laws, rules and regulations of all government authorities, including, without limitation, export laws, (b) obtain all permits and licenses required in connection with the purchase, shipment, installation or use of the Equipment, and (c) be solely responsible to fully understand and comply with laws, rules and regulations. Any information provided is as a convenience only.

        19.  FURTHER ASSURANCES. Upon MRP’s reasonable request, Buyer shall, at its sole cost and expense, execute and deliver all such further documents and instruments, and take all such further acts, necessary to give full effect to this Agreement.

        20.  ASSIGNMENT; SUCCESSORS AND ASSIGNS. Buyer cannot delegate any duties nor assign any rights or claims under this Agreement without MRP’s prior written consent, and any such attempt or assignment shall be void. In the event that Buyer finances its acquisition of any Equipment with a third party, Buyer may direct MRP to transfer title of such Equipment to such third-party financing company, with all remaining terms and conditions of this Agreement remaining in full force and effect. This Agreement is binding on and inures to the benefit of the parties to this Agreement and their respective permitted successors and permitted assigns.

        21.  NO THIRD-PARTY BENEFICIARIES. Subject to Section 16, this Agreement benefits solely the parties to this Agreement and their respective permitted successors and assigns, and nothing in this Agreement, express or implied, confers on any other person any legal or equitable right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

        22.  GOVERNING LAW; VENUE. The application of the UN Convention on Contracts for the International Sale of Goods is expressly excluded. The parties agree that any and all claims, demands, disagreements, controversies or disputes arising out of or relating to this Agreement and any agreement or document delivered in connection herewith (collectively, “Claims”) shall be governed by and construed in accordance with the laws of the State of Utah and adjudicated exclusively in the state and federal courts located in or nearest to Summit County, Utah, which courts shall have the sole and exclusive jurisdiction and venue for adjudication of all Claims. The parties hereby agree upon, consent and stipulate to the jurisdiction and venue of the aforementioned courts for the adjudication of all Claims, to the exclusion of all other courts, forums and venues whatsoever.

        23.  NON-DISPARAGEMENT. Buyer shall not disparage MRP or MRP’s trademarks, websites, products or services, or display any such items in a derogatory or negative manner on any website or in any public forum or press release.

        24.  NOTICES. Any notice, demand, or communication required, permitted or desired to be given hereunder shall be deemed effectively given when personally delivered, when sent by electronic means, when received by overnight courier, or when mailed by prepaid, certified or registered mail, return receipt requested, addressed to the other party at its address set forth on the Quote or to such other address that the receiving party may designate from time to time in accordance with this Section 25.

        25.  PUBLIC ANNOUNCEMENTS. Unless otherwise stated herein, neither party shall issue a press release or otherwise advertise, make a public statement or disclose to any third-party information pertaining to the relationship arising under this Agreement, the existence or terms of this Agreement, the underlying transactions between MRP and Buyer or agent for Buyer or refer to the other party in relation to this Agreement without the other party’s prior written approval.

        26.  ENTIRE AGREEMENT; ADDITIONAL OR INCONSISTENT TERMS. Subject to Section 32, this Agreement constitutes the sole and entire agreement between the parties hereto relating to the subject matter hereof, and any unincorporated representation, affirmation of fact, course of prior dealings, promise or condition in connection therewith, or usage of the trade, shall not be binding on either party. Terms and conditions set forth which differ from, conflict with or are not included in this Agreement shall not be part of any agreement between MRP and Buyer unless both parties specifically accept such terms and conditions in writing.

        27.  WAIVER. No waiver under this Agreement is effective unless it is in writing and signed by the party waiving its right. Any waiver authorized on one occasion is effective only in that instance and only for the purpose stated and does not operate as a waiver on any future occasion. None of the following constitutes a waiver or estoppel of any right, remedy, power, privilege or condition arising from this Agreement: any failure or delay in exercising any right, remedy, power or privilege or in enforcing any condition under this Agreement; or any act, omission or course of dealing between the parties.

        28.  SURVIVAL. Subject to the limitations and other provisions of this Agreement, the representations and warranties of Buyer contained herein shall survive the expiration or earlier termination of this Agreement for a period of twelve (12) months after such expiration o termination and (b) this Section 29 and Sections 10, 12, 13, 14, 15, 16, 17, 21, 22, 23, 24, 26, and 32 of this Agreement, as well as any other provision that, in order to give proper effect to its intent, should survive such expiration or termination, shall survive the expiration or earlier termination of this Agreement. All other provisions of this Agreement shall not survive the expiration or earlier termination of this Agreement.

        29.  RELATIONSHIP OF PARTIES. Nothing in this Agreement creates any agency, joint venture, partnership or other form of joint enterprise, employment or fiduciary relationship between the parties. Neither party has any express or implied right or authority to assume or create any obligations on behalf of or in the name of the other party or to bind the other party to any contract, agreement or undertaking with any third party.

        30.  HEADINGS. The headings in this Agreement are for reference only and do not affect the interpretation of this Agreement.

        31.  ORDER OF PRECEDENCE. In the event of conflict between the Quote, a written agreement by MRP, and these Terms, the order of priority shall be: (1) the written

agreement by MRP, if only if executed by an MRP Officer, (2) the Quote and (3) these Terms, and only to the extent of the direct conflict. Notwithstanding the foregoing, MRP shall not be bound by, and specifically objects to, any terms, conditions or other provisions, both written and oral, which are different from, in addition to or inconsistent with the provisions of this Agreement which are set forth in any purchase order, receipt, acceptance, confirmation, correspondence or otherwise of, or by, Buyer. Fulfillment of Buyer’s order shall not constitute acceptance of any of Buyer’s terms and conditions and does not serve to modify or amend the terms and conditions contained herein.

        32.  SEVERABILITY. If any part of this Agreement is held to be void, illegal or unenforceable, then it shall be deemed to be severed from this Agreement and the remaining provisions shall continue in full force and effect; provided, however, that if any fundamental term or provision of this Agreement is held to be void, illegal or unenforceable, the remainder of this Agreement shall be unenforceable. Upon a determination that any term or provision is void, illegal or unenforceable, the parties shall negotiate in good faith to modify this Agreement to effect the original intent of the parties as closely as possible in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.